216 related articles for article (PubMed ID: 36097176)
1. A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannoma.
Paterson C; Bozic I; Smith MJ; Hoad X; Evans DGR
Br J Cancer; 2022 Nov; 127(10):1843-1857. PubMed ID: 36097176
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
3. Genetic landscape of sporadic vestibular schwannoma.
Håvik AL; Bruland O; Myrseth E; Miletic H; Aarhus M; Knappskog PM; Lund-Johansen M
J Neurosurg; 2018 Mar; 128(3):911-922. PubMed ID: 28409725
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
[TBL] [Abstract][Full Text] [Related]
5. Sporadic vestibular schwannoma: a molecular testing summary.
Sadler KV; Bowers NL; Hartley C; Smith PT; Tobi S; Wallace AJ; King A; Lloyd SKW; Rutherford S; Pathmanaban ON; Hammerbeck-Ward C; Freeman S; Stapleton E; Taylor A; Shaw A; Halliday D; Smith MJ; Evans DG
J Med Genet; 2021 Apr; 58(4):227-233. PubMed ID: 32576656
[TBL] [Abstract][Full Text] [Related]
6. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma.
Håvik AL; Bruland O; Miletic H; Poulsgaard L; Scheie D; Fugleholm K; Lund-Johansen M; Knappskog PM
Acta Neurochir (Wien); 2022 Feb; 164(2):343-352. PubMed ID: 34816314
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation in vestibular schwannoma: report of a single case, literature search, and debate.
Seferis C; Torrens M; Paraskevopoulou C; Psichidis G
J Neurosurg; 2014 Dec; 121 Suppl():160-6. PubMed ID: 25434949
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite analysis of recurrent vestibular schwannoma (acoustic neuroma) following stereotactic radiosurgery.
Lee DJ; Maseyesva B; Westra W; Long D; Niparko JK; Califano J
Otol Neurotol; 2006 Feb; 27(2):213-9. PubMed ID: 16436992
[TBL] [Abstract][Full Text] [Related]
11. Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants.
Carlson ML; Smadbeck JB; Link MJ; Klee EW; Vasmatzis G; Schimmenti LA
Otol Neurotol; 2018 Oct; 39(9):e860-e871. PubMed ID: 30106846
[TBL] [Abstract][Full Text] [Related]
12. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
[TBL] [Abstract][Full Text] [Related]
13. Late malignant transformation of vestibular schwannoma in the absence of irradiation: case report.
Bashir A; Poulsgaard L; Broholm H; Fugleholm K
J Neurosurg; 2016 Aug; 125(2):372-7. PubMed ID: 26613171
[TBL] [Abstract][Full Text] [Related]
14. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Reported Malignant Transformation of Vestibular Schwannoma: De Novo and After Stereotactic Radiosurgery or Surgery.
Maducdoc MM; Ghavami Y; Linskey ME; Djalilian HR
Otol Neurotol; 2015 Sep; 36(8):1301-8. PubMed ID: 26134937
[TBL] [Abstract][Full Text] [Related]
17. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
[TBL] [Abstract][Full Text] [Related]
18. The molecular genetics of vestibular schwannoma.
Moffat DA; Irving RM
J Laryngol Otol; 1995 May; 109(5):381-4. PubMed ID: 7797991
[TBL] [Abstract][Full Text] [Related]
19. [Neurotrophic factor expression in vestibular schwannoma. An overview].
Diensthuber M; Lenarz T; Stöver T
Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
[TBL] [Abstract][Full Text] [Related]
20. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]